Tyme Technologies Inc's

• TYME's Stock Performance relative to its Competitors

Terns Pharmaceuticals Inc Share Performance +54.82% This Quarter

Terns Pharmaceuticals Inc Profile Terns Pharmaceuticals Inc. is a biopharmaceutical company. More about Terns Pharmaceuticals Inc 's Market Share

Zai Lab Limited Share Performance +44.14% This Year

Zai Lab Limited Profile Zai Lab Limited operates as a biopharmaceutical company primarily in China. The company seeks to discover, develop, and commercialize innovative medicines to address unmet medical needs in the country. Zai Lab focuses on licensing and acquiring clinical stage or late-stage development drugs, and then progressing them through regulatory approval and commercial launch. More about Zai Lab Limited's Market Share

Xencor Inc Share Performance +64.71% This Quarter

Xencor Inc Profile Xencor Inc is a biotechnology company that primarily focuses on the development of therapeutic antibodies. Their business model revolves around utilizing their proprietary XmAb® technology to engineer antibodies with enhanced properties for the treatment of various diseases. They collaborate with pharmaceutical companies to develop and commercialize these antibody therapeutics, generating revenue through upfront payments, milestone payments, and royalties. More about Xencor Inc's Market Share

Deciphera Pharmaceuticals Inc Share Performance +82.52% One Year

Deciphera Pharmaceuticals Inc Profile Deciphera Pharmaceuticals Inc's business model revolves around the research, development, and commercialization of precision medicines for the treatment of cancer and other serious diseases. More about Deciphera Pharmaceuticals Inc 's Market Share

Mannkind Corporation Share Performance -13.02% This Quarter

Mannkind Corporation Profile MannKind Corporation is a biopharmaceutical company that focuses on the development and commercialization of inhaled therapeutic solutions for patients with diseases such as diabetes and pulmonary arterial hypertension. The company's business model revolves around conducting research and development to create innovative inhalation therapies and gaining regulatory approvals for these treatments. They then market and distribute their products, either directly or through partnerships, to healthcare providers and patients worldwide. More about Mannkind Corporation's Market Share

Sources: Tyme Technologies Inc.’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, September 26, 2026 8:46 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Tyme Technologies Inc. versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.